"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops.
Today's guests: Wei Li, BlackRock Global Chief Investment Strategist; Vincent Policard, KKR Co-Head of European Infrastructure; Luigi Lovaglio, Banca Monte dei Paschi di Siena CEO (Source: Bloomberg)
(RTTNews) - The following biotech stocks reached a 52-week high on September 29, 2026, driven by key catalysts such as promising results from clinical trials or revised financial guidance.
Iovance Biotherapeutics (IOVA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
(RTTNews) - On Wednesday Pyxis Oncology (PYXS), a clinical-stage biopharmaceutical, announced the pricing of its previously announced public offering, expected to generate approximately $110 million in gross proceeds.